1. Home
  2. IMXI vs LXEO Comparison

IMXI vs LXEO Comparison

Compare IMXI & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

HOLD

Current Price

$11.35

Market Cap

469.3M

Sector

Technology

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$4.87

Market Cap

396.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMXI
LXEO
Founded
1994
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
469.3M
396.5M
IPO Year
2016
2023

Fundamental Metrics

Financial Performance
Metric
IMXI
LXEO
Price
$11.35
$4.87
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$15.00
$18.44
AVG Volume (30 Days)
385.0K
971.8K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.81
EPS
0.15
N/A
Revenue
$319,601,000.00
$654,000.00
Revenue This Year
$0.83
N/A
Revenue Next Year
$1.49
N/A
P/E Ratio
$77.53
N/A
Revenue Growth
16.68
N/A
52 Week Low
$11.15
$3.99
52 Week High
$15.95
$10.99

Technical Indicators

Market Signals
Indicator
IMXI
LXEO
Relative Strength Index (RSI) 26.67 57.53
Support Level $11.15 $4.39
Resistance Level $15.49 $5.01
Average True Range (ATR) 0.54 0.30
MACD -0.08 0.06
Stochastic Oscillator 11.06 84.79

Price Performance

Historical Comparison
IMXI
LXEO

About IMXI International Money Express Inc.

International Money Express Inc is an omnichannel money remittance services company focused on the United States of America to Latin America and the Caribbean corridor, which includes Mexico, Central and South America and the Caribbean. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Share on Social Networks: